Efficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer

• Yasushi Hamaya,

  Affiliation Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America

  ⨯
• Carla Guarinos,

  Affiliations Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America, Unidad de Gastroenterologia, Hospital General Universitario de Alicante, Alicante, Spain

  ⨯
• Stephanie S. Tseng-Rogenski,

  Affiliation Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America

  ⨯
• Moriya Iwaizumi,

  Affiliation Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America

  ⨯
• Ritabrata Das,

  Affiliation Biostatistics Department, School of Public Health, University of Michigan, Ann Arbor, Michigan, United States of America

  ⨯
• Rodrigo Jover,

  Affiliation Unidad de Gastroenterologia, Hospital General Universitario de Alicante, Alicante, Spain

  ⨯
• Antoni Castells,

  Affiliation Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd), IDIBAPS, University of Barcelona, Barcelona, Spain

  ⨯
• Xavier Llor,

  Affiliation Division of Gastroenterology, Department of Medicine, Yale University, New Haven, Connecticut, United States of America

  ⨯
• Montserrat Andreu,

  Affiliation Department of Gastroenterology, Hospital del Mar, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Pompeu Fabra University, Barcelona, Catalonia, Spain

  ⨯
• John M. Carethers

  * E-mail: jcarethe@umich.edu

  Affiliation Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America

  ⨯